Balyasny Asset Management LLC Esperion Therapeutics, Inc. Call Options Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $2.42 Million - $3.58 Million	-100,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $1.56 Million - $2.64 Million	50,000 Added 100.0%	100,000 $3.72 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $2.06 Million - $5.54 Million	-75,000 Reduced 60.0%	50,000 $1.58 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $4.43 Million - $7.48 Million	125,000 New	125,000 $7.45 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $4.33 Million - $5.79 Million	-108,000 Closed	0 $0

Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $3.99 Million - $6.38 Million	108,000 New	108,000 $4.97 Million

174

125M

2.08M

1.01M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.